Theranostics
Moreover, the relationship between the 23-marker AAb panel and the response of cancer patients to the anti-PD1 therapy was investigated. Materials and Methods. Study design and patient characteristics. Plasma samples from patients receiving anti-PD1 therapy (Sintilimab, Toripalimab, ... Predictive potential of PD1,PDL1 … ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.